HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yusuke Nagatani Selected Research

ONO 8809

10/2021Thromboxane A2 receptor antagonist (ONO-8809) attenuates renal disorders caused by salt overload in stroke-prone spontaneously hypertensive rats.
4/2007Involvement of thromboxane A2 receptor in the cerebrovascular damage of salt-loaded, stroke-prone rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yusuke Nagatani Research Topics

Disease

2Stroke (Strokes)
10/2021 - 04/2007
1Hypoxia (Hypoxemia)
10/2021
1Hypertension (High Blood Pressure)
10/2021
1Chronic Renal Insufficiency
10/2021
1Inflammation (Inflammations)
04/2007
1Cardiovascular Diseases (Cardiovascular Disease)
08/2004
1Myocardial Infarction
08/2004

Drug/Important Bio-Agent (IBA)

2Prostaglandin H2 Thromboxane A2 ReceptorsIBA
10/2021 - 04/2007
2Thromboxane A2 (A2, Thromboxane)IBA
10/2021 - 04/2007
2SaltsIBA
10/2021 - 04/2007
2ONO 8809IBA
10/2021 - 04/2007
13-nitrotyrosineIBA
10/2021
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2021
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
04/2007
1Thromboxane Receptors (Thromboxane Receptor)IBA
04/2007
18-epi-prostaglandin F2alphaIBA
04/2007
1NitratesIBA
08/2004